Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ATRenew (RERE) Equity Income: 2020-2025

Historic Equity Income for ATRenew (RERE) over the last 6 years, with Q3 2025 value amounting to -$17.5 million.

  • ATRenew's Equity Income rose 337.04% to -$17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.1 million, marking a year-over-year increase of 913.87%. This contributed to the annual value of -$8.9 million for FY2024, which is 2428.38% down from last year.
  • Per ATRenew's latest filing, its Equity Income stood at -$17.5 million for Q3 2025, which was up 337.04% from -$10.0 million recorded in Q2 2025.
  • In the past 5 years, ATRenew's Equity Income registered a high of $735000.0 during Q2 2021, and its lowest value of -$30.6 million during Q3 2023.
  • For the 5-year period, ATRenew's Equity Income averaged around -$9.1 million, with its median value being -$3.2 million (2022).
  • Per our database at Business Quant, ATRenew's Equity Income soared by 14081.07% in 2021 and then plummeted by 242322.9% in 2023.
  • Quarter analysis of 5 years shows ATRenew's Equity Income stood at -$1.3 million in 2021, then surged by 76.64% to -$307000.0 in 2022, then plummeted by 527.04% to -$1.9 million in 2023, then tumbled by 504.47% to -$11.6 million in 2024, then tumbled by 50.05% to -$17.5 million in 2025.
  • Its last three reported values are -$17.5 million in Q3 2025, -$10.0 million for Q2 2025, and -$23.6 million during Q1 2025.